This review explores botulinum toxin's applications in oral and maxillofacial surgery, highlighting its safety and future potential.
AbstractBotulinum toxin (BTX), originally infamous for causing botulism, has emerged as a versatile and minimally invasive therapeutic and cosmetic tool in oral and maxillofacial surgery (OMFS). Its ability to selectively induce temporary, localized muscle paralysis with a favourable safety profile has revolutionized the management of functional, aesthetic, and pain-related conditions in the maxillofacial region. This review consolidates current literature, focusing on the physiology, mechanism of action, clinical applications, and safety considerations of BTX in OMFS, while highlighting recent advances and future prospects.
No takes yet. Share an insight, caveat, or question.
Kavya Sharma (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: